Alpelisib is an oral medication that specifically inhibits the enzyme PI3K (phosphoinositide 3-kinase) in cancer cells. This enzyme plays a crucial role in several cellular functions, including growth, proliferation, and survival. Alpelisib is particularly effective in targeting the PI3K pathway, which is often overactive in certain types of cancer, leading to uncontrolled cell growth.